These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7880108)

  • 1. [Strategies for the overcoming of drug resistance].
    Saijo N
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):371-81. PubMed ID: 7880108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].
    Liu L; Bian K
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3216-20. PubMed ID: 25522600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of acquired resistance to DNA topoisomerase I inhibitors].
    Okada K; Andoh T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1562-7. PubMed ID: 1651683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I inhibitors. An overview of the camptothecin analogs.
    Burris HA; Fields SM
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):333-55. PubMed ID: 8040144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.
    Pantazis P
    Clin Cancer Res; 1995 Nov; 1(11):1235-44. PubMed ID: 9815917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
    Chang JY; Liu JF; Juang SH; Liu TW; Chen LT
    Cancer Res; 2002 Jul; 62(13):3716-21. PubMed ID: 12097280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic drug resistance in brain tumors.
    Phillips PC
    Neurol Clin; 1991 May; 9(2):383-404. PubMed ID: 1682794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug resistance and implication for therapy].
    Tsuruo T
    Rinsho Ketsueki; 1989 Aug; 30(8):1128-32. PubMed ID: 2574754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of SN-38 in combination with other anticancer agents against Dauji cells].
    Akutsu M; Suzuki K; Tsunoda S; Kano Y; Miura Y
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1607-11. PubMed ID: 8060135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination cancer chemotherapy using a DNA topoisomerase inhibitor CPT-11, as a core agent--the in vitro evaluation].
    Oguro M; Seki Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1556-61. PubMed ID: 1651682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between antitumour agents and radiation and the expression of resistance.
    Hill BT
    Cancer Treat Rev; 1991 Sep; 18(3):149-90. PubMed ID: 1821327
    [No Abstract]   [Full Text] [Related]  

  • 14. [DNA topoisomerases and resistance to anticancer agents].
    Andoh T; Okada K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):569-75. PubMed ID: 2539786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological evaluation of chemo-radiotherapy combined with cisplatin].
    Sasaki T; Miura M
    Gan No Rinsho; 1990 Oct; 36(13):2234-43. PubMed ID: 2250343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of antileukaemic drugs.
    Brusamolino E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
    [No Abstract]   [Full Text] [Related]  

  • 19. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.
    Kanzawa F; Sugimoto Y; Minato K; Kasahara K; Bungo M; Nakagawa K; Fujiwara Y; Liu LF; Saijo N
    Cancer Res; 1990 Sep; 50(18):5919-24. PubMed ID: 2168285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.